Historic funding from the Swedish Cancer Society with focus on early detection

This year's decision from the Swedish Cancer Society's Research Board means that just over SEK 1 billion will go to new cancer research. It is the largest investment in the history of the Swedish Cancer Society. KI is granted SEK 447.8 million to 104 research projects and 3 planning groups. This year, a special investment is also being made in the area of early detection of cancer.

The Swedish Research Council awards KI 106 grants in three calls for proposals

The Swedish Research Council has decided on a number of calls for proposals in medicine and health for 2025. KI will receive just over SEK 526 million for 102 grants. KI is also being awarded four grants in natural and engineering sciences, and humanities and social sciences, totalling approximately SEK 18.7 million.

Mona Ståhle receives the Sven Hellerström Medal for research in dermatology

Professor Mona Ståhle has been awarded the Sven Hellerström Medal by the Swedish Society of Medicine for her significant contributions to dermatological research. The award committee highlights how, over four decades, she has been a visionary leader at Karolinska Institutet, particularly in psoriasis research, and has educated an entire generation of clinician-scientists in Sweden

Fredrik Lundberg donates SEK 30 million to colorectal cancer research

Businessman Fredrik Lundberg is donating SEK 30 million to Karolinska Institutet and a research project looking into how the immune system can combat colorectal cancer and prevent it spreading.

The 2025 Nobel Prize in Physiology or Medicine to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi

The Nobel Assembly at Karolinska Institutet has decided to award the 2025 Nobel Prize in Physiology or Medicine jointly to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for their discoveries concerning peripheral immune tolerance.

This year’s Nobel prizes in Chemistry and Physics equally valuable to life science

Do all heart attack patients need beta blockers? A cardiologist explains

Beta blockers have long been prescribed to almost everyone who has suffered a heart attack, but new research shows that their effect depends on the heart's pumping capacity. While some patients clearly benefit from the treatment, it appears to be unnecessary—or even risky—for others. Read the news article in The Conversation.

Gene therapy restores hearing in congenital deafness

Popular weight-loss drugs linked to rare but serious eye conditions

More articles by KI researchers published in The Conversation

From cold-resistant genes to face masks, Karolinska Institutet researchers contribute to the global public discourse on a range of topics through our collaboration with the international news site The Conversation.